Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 17:42 | 2026-04-09 | PHVS | Pharvaris N.V. | Modig Berndt | Director, Officer | SELL | $27.74 | 23,333 | $647,281 | 142,084 |
| 2026-04-09 21:38 | 2026-04-07 | ACET | Adicet Bio, Inc. | ORBIMED ADVISORS LLC | 10% owner | SELL | $6.45 | 104,658 | $674,845 | 0 |
| 2026-04-09 20:30 | 2026-04-08 | RAPP | Rapport Therapeutics, Inc. | Yeleswaram Krishnaswamy | Officer | SELL | $34.90 | 360 | $12,564 | 286,516 |
| 2026-04-09 20:30 | 2026-04-08 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $580.45 | 9,500 | $5,514,306 | 40,513 |
| 2026-04-09 18:43 | 2026-04-08 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | Heshmatpour Amir F | Director, Officer, 10% owner | BUY | $5.47 | 15,000 | $82,001 | 3,032,000 |
| 2026-04-09 00:32 | 2026-04-06 | WHWK | Whitehawk Therapeutics, Inc. | Lennon David James | Director, Officer | SELL | $3.45 | 260,427 | $899,541 | 533,122 |
| 2026-04-08 23:33 | 2026-04-06 | ZLAB | Zai Lab Ltd | Amado Rafael | Officer | SELL | $20.45 | 2,739 | $56,007 | 57,022 |
| 2026-04-08 23:33 | 2026-04-06 | ZLAB | Zai Lab Ltd | Chen Yajing | Officer | SELL | $20.45 | 853 | $17,442 | 31,705 |
| 2026-04-08 23:34 | 2026-04-06 | ZLAB | Zai Lab Ltd | Du Ying | Director, Officer | SELL | $20.45 | 2,653 | $54,249 | 1,122,626 |
| 2026-04-08 23:34 | 2026-04-06 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | Officer | SELL | $20.45 | 1,224 | $25,028 | 23,366 |
| 2026-04-08 23:34 | 2026-04-07 | CORT | CORCEPT THERAPEUTICS INC | Guyer William | Officer | OPT+S | $40.97 | 20,000 | $819,400 | 2,231 |
| 2026-04-08 23:35 | 2026-04-06 | ZLAB | Zai Lab Ltd | Smiley Joshua L | Officer | SELL | $20.45 | 3,017 | $61,692 | 117,602 |
| 2026-04-08 21:20 | 2026-04-06 | PTCT | PTC THERAPEUTICS, INC. | Boulding Mark Elliott | Officer | OPT+S | $69.45 | 2,265 | $157,293 | 105,212 |
| 2026-04-08 20:39 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Moat Ross | Officer | OPT+S | $48.58 | 2,367 | $114,989 | 12,029 |
| 2026-04-08 20:41 | 2026-04-06 | INSM | INSMED Inc | Lewis William | Director, Officer | OPT+S | $163.22 | 10,699 | $1,746,336 | 301,185 |
| 2026-04-08 20:43 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Patel Sanj K | Director, Officer | OPT+S | $50.01 | 7,278 | $363,973 | 0 |
| 2026-04-08 20:51 | 2026-04-06 | AVTX | Avalo Therapeutics, Inc. | Doyle Mittie | Officer | OPT+S | $18.01 | 3,970 | $71,508 | 3,622 |
| 2026-04-08 20:23 | 2026-04-06 | NUVB | Nuvation Bio Inc. | Wentworth Kerry | Officer | OPT+S | $4.52 | 200,000 | $903,560 | 53,000 |
| 2026-04-08 20:30 | 2026-04-06 | NUVL | Nuvalent, Inc. | Porter James Richard | Director, Officer | OPT+S | $103.77 | 30,000 | $3,113,232 | 324,879 |
| 2026-04-08 20:33 | 2026-04-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $564.01 | 9,500 | $5,358,116 | 40,513 |
| 2026-04-08 20:34 | 2026-04-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Quart Barry D | Director | OPT+S | $50.00 | 6,901 | $345,050 | 12,546 |
| 2026-04-08 20:18 | 2026-04-07 | CYTK | CYTOKINETICS INC | Malik Fady Ibraham | Officer | OPT+S | $65.11 | 4,500 | $292,985 | 153,902 |
| 2026-04-07 23:55 | 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Officer | OPT+S | $22.20 | 1,030 | $22,866 | 27,865 |
| 2026-04-07 23:57 | 2026-04-07 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | Officer | OPT+S | $22.20 | 2,709 | $60,140 | 62,836 |
| 2026-04-07 22:27 | 2026-04-07 | LPCN | Lipocine Inc. | Higuchi John W. | Director | BUY | $2.03 | 40,000 | $81,200 | 203,797 |
| 2026-04-07 22:17 | 2026-04-06 | TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Director | OPT+S | $33.00 | 10,000 | $330,000 | 37,500 |
| 2026-04-07 20:35 | 2026-04-06 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $558.41 | 9,500 | $5,304,905 | 40,513 |
| 2026-04-07 20:35 | 2026-04-06 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $558.40 | 10,000 | $5,583,999 | 18,876 |
| 2026-04-07 20:21 | 2026-04-02 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | McLaughlin Melissa | Officer | SELL | $325.92 | 3,910 | $1,274,343 | 9,443 |
| 2026-04-07 00:55 | 2026-04-02 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | Heshmatpour Amir F | Director, Officer, 10% owner | BUY | $6.14 | 25,000 | $153,398 | 3,017,000 |
| 2026-04-06 23:56 | 2026-04-06 | ALKS | Alkermes plc. | Gaffin David Joseph | Officer | SELL | $34.57 | 2,034 | $70,315 | 233,592 |
| 2026-04-06 23:01 | 2026-04-06 | LPCN | Lipocine Inc. | Higuchi John W. | Director | BUY | $2.05 | 123,000 | $252,150 | 163,797 |
| 2026-04-06 22:30 | 2026-04-02 | BCYC | BICYCLE THERAPEUTICS PLC | Skynner Michael | Officer | SELL | $4.94 | 2,404 | $11,877 | 159,562 |
| 2026-04-06 22:30 | 2026-04-02 | BCYC | BICYCLE THERAPEUTICS PLC | Lee Kevin | Director, Officer | SELL | $4.94 | 7,683 | $37,964 | 611,313 |
| 2026-04-06 22:30 | 2026-04-02 | BCYC | BICYCLE THERAPEUTICS PLC | Perry Jennifer Scott | Officer | SELL | $4.94 | 1,408 | $6,962 | 92,464 |
| 2026-04-06 22:30 | 2026-04-02 | BCYC | BICYCLE THERAPEUTICS PLC | Thompson Travis Alvin | Officer | SELL | $4.93 | 901 | $4,438 | 65,364 |
| 2026-04-06 22:30 | 2026-04-02 | BCYC | BICYCLE THERAPEUTICS PLC | Hannay Michael Charles Ferguson | Officer | SELL | $4.93 | 1,772 | $8,736 | 96,136 |
| 2026-04-06 22:33 | 2026-04-06 | LPCN | Lipocine Inc. | Patel Mahesh V. | Director, Officer | BUY | $2.03 | 25,000 | $50,750 | 160,679 |
| 2026-04-06 21:43 | 2026-04-06 | CTNM | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Officer | SELL | $13.43 | 4,170 | $56,014 | 147,712 |
| 2026-04-06 21:32 | 2026-04-02 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% owner | SELL | $4.81 | 24,925 | $119,889 | 401,891 |
| 2026-04-06 21:20 | 2026-04-02 | PTCT | PTC THERAPEUTICS, INC. | Golden Lee Scott | Officer | SELL | $67.99 | 829 | $56,364 | 79,115 |
| 2026-04-06 20:41 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $561.50 | 10,000 | $5,614,984 | 18,876 |
| 2026-04-06 20:42 | 2026-04-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $561.37 | 9,500 | $5,333,053 | 40,513 |
| 2026-04-06 20:07 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Milanova Tsveta | Officer | OPT+S | $34.71 | 3,262 | $113,224 | 46,829 |
| 2026-04-06 20:08 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia | Officer | OPT+S | $34.71 | 3,141 | $109,024 | 54,998 |
| 2026-04-06 20:10 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Officer | OPT+S | $34.71 | 2,940 | $102,047 | 80,277 |
| 2026-04-06 20:11 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Burns James William | Officer | OPT+S | $34.71 | 3,280 | $113,849 | 49,306 |
| 2026-04-06 20:04 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Goff Brian | Director, Officer | OPT+S | $34.71 | 19,068 | $661,850 | 184,508 |
| 2026-04-06 20:05 | 2026-04-06 | ALT | Altimmune, Inc. | GILL JOHN | Director | BUY | $3.41 | 9,200 | $31,350 | 21,700 |
| 2026-04-06 20:05 | 2026-04-02 | AGIO | AGIOS PHARMACEUTICALS, INC. | Viswanadhan Krishnan | Officer | OPT+S | $34.71 | 2,959 | $102,707 | 10,282 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.